Biosergen AB (publ) (STO:BIOSGN)
Sweden · Delayed Price · Currency is SEK 9.10
-0.70 (-7.14%)
May 21, 2026, 12:20 PM CET
Biosergen AB Market Cap
Biosergen AB has a market cap or net worth of 23.01 million as of May 21, 2026. Its market cap has decreased by -67.22% in one year.
Market Cap
23.01M
Enterprise Value
7.64M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
9.10
Market Cap Chart
Since June 24, 2021, Biosergen AB's market cap has decreased from 197.72M to 23.01M, a decrease of -88.36%. That is a compound annual growth rate of -35.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 23.01M | -75.20% |
| Dec 30, 2025 | 92.80M | -25.43% |
| Dec 30, 2024 | 124.46M | 179.03% |
| Dec 29, 2023 | 44.60M | 0.12% |
| Dec 30, 2022 | 44.55M | -70.75% |
| Dec 30, 2021 | 152.31M | -22.97% |
| Jun 24, 2021 | 197.72M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Spago Nanomedical AB | 87.33M |
| Pila Pharma AB | 82.00M |
| Alzinova AB | 68.11M |
| Modus Therapeutics Holding AB | 59.84M |
| 2cureX AB | 54.22M |
| Fluicell AB | 41.62M |
| Guard Therapeutics International AB | 26.82M |
| NanoEcho AB | 17.94M |